Senhwa Announces First Patient Successfully Dosed in Phase 1b Expansion Study of Pidnarulex to Treat Solid Tumors with Specific Homologous Recombination Gene Mutations

Senhwa Announces First Patient Successfully Dosed In Phase 1b Expansion Study Of Pidnarulex To Treat Solid Tumors With Specific Homologous Recombination Gene Mutations

Facebook Comments

Leave a Reply

CommentLuv badge